Results
|
|
3301.
|
|
|
|
3302.
|
A Phase II trial of split, low-dose docetaxel and low-dose capecitabine: a tolerable and efficacious regimen in the first-line treatment of patients with HER2/neu-negative metastatic breast cancer. [electronic resource] by
- Silva, Orlando
- Lopes, Gilberto
- Morgenzstern, Daniel
- Lobo, Christopher
- Doliny, Philomena
- Santos, Edgardo
- Abdullah, Sakher
- Gautam, Umang
- Reis, Isildinha
- Welsh, Catherine
- Slingerland, Joyce
- Hurley, Judith
- Gluck, Stefan
Producer: 20080909
In:
Clinical breast cancer vol. 8
Availability: No items available.
|
|
|
3303.
|
|
|
|
3304.
|
|
|
|
3305.
|
|
|
|
3306.
|
|
|
|
3307.
|
|
|
|
3308.
|
|
|
|
3309.
|
|
|
|
3310.
|
Increased mitochondrial DNA induces acquired docetaxel resistance in head and neck cancer cells. [electronic resource] by
- Mizumachi, T
- Suzuki, S
- Naito, A
- Carcel-Trullols, J
- Evans, T T
- Spring, P M
- Oridate, N
- Furuta, Y
- Fukuda, S
- Higuchi, M
Producer: 20080228
In:
Oncogene vol. 27
Availability: No items available.
|
|
|
3311.
|
|
|
|
3312.
|
Multiple rechallenges for castration-resistant prostate cancer patients responding to first-line docetaxel: assessment of clinical outcomes and predictive factors. [electronic resource] by
- Caffo, Orazio
- Pappagallo, Giovanni
- Brugnara, Sonia
- Caldara, Alessia
- di Pasquale, Maria Chiara
- Ferro, Antonella
- Frisinghelli, Michela
- Murgia, Viviana
- Russo, Lucianna Maria
- Soini, Barbara
- Valduga, Francesco
- Veccia, Antonello
- Galligioni, Enzo
Producer: 20120518
In:
Urology vol. 79
Availability: No items available.
|
|
|
3313.
|
GDC-0941, a novel class I selective PI3K inhibitor, enhances the efficacy of docetaxel in human breast cancer models by increasing cell death in vitro and in vivo. [electronic resource] by
- Wallin, Jeffrey J
- Guan, Jane
- Prior, Wei Wei
- Lee, Leslie B
- Berry, Leanne
- Belmont, Lisa D
- Koeppen, Hartmut
- Belvin, Marcia
- Friedman, Lori S
- Sampath, Deepak
Producer: 20130403
In:
Clinical cancer research : an official journal of the American Association for Cancer Research vol. 18
Availability: No items available.
|
|
|
3314.
|
Multicenter phase II study of S-1 and docetaxel combination chemotherapy for advanced or recurrent gastric cancer patients with peritoneal dissemination. [electronic resource] by
- Shigeyasu, Kunitoshi
- Kagawa, Shunsuke
- Uno, Futoshi
- Nishizaki, Masahiko
- Kishimoto, Hiroyuki
- Gochi, Akira
- Kimura, Toshikazu
- Takahata, Takaomi
- Nonaka, Yasuyuki
- Ninomiya, Motoki
- Fujiwara, Toshiyoshi
Producer: 20130613
In:
Cancer chemotherapy and pharmacology vol. 71
Availability: No items available.
|
|
|
3315.
|
Prospective multicenter randomized phase III study of weekly versus standard docetaxel (D2) for first-line treatment of metastatic breast cancer. [electronic resource] by
- Stemmler, Hans-Joachim
- Harbeck, Nadia
- Gröll de Rivera, Isolde
- Vehling Kaiser, Ursula
- Rauthe, Gerhard
- Abenhardt, Wolfgang
- Artmann, Almut
- Sommer, Harald
- Meerpohl, Hans-Gerd
- Kiechle, Marion
- Heinemann, Volker
Producer: 20110531
In:
Oncology vol. 79
Availability: No items available.
|
|
|
3316.
|
Weekly docetaxel and cisplatin with concomitant radiotherapy in addition to surgery and/or consolidation chemotherapy in stage III non-small cell lung cancer. [electronic resource] by
- Sen, Fatma
- Saglam, Esra Kaytan
- Toker, Alper
- Dilege, Sukru
- Kizir, Ahmet
- Oral, Ethem Nezih
- Saip, Pinar
- Sakallioglu, Barkin
- Topuz, Erkan
- Aydiner, Adnan
Producer: 20120111
In:
Cancer chemotherapy and pharmacology vol. 68
Availability: No items available.
|
|
|
3317.
|
|
|
|
3318.
|
|
|
|
3319.
|
|
|
|
3320.
|
|